GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Athanase Innovation AB (OSTO:ATIN) » Definitions » Capex-to-Revenue

Athanase Innovation AB (OSTO:ATIN) Capex-to-Revenue : 0.00 (As of Dec. 2020)


View and export this data going back to 2017. Start your Free Trial

What is Athanase Innovation AB Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Athanase Innovation AB's Capital Expenditure for the six months ended in Dec. 2020 was kr0.00 Mil. Its Revenue for the six months ended in Dec. 2020 was kr0.35 Mil.

Hence, Athanase Innovation AB's Capex-to-Revenue for the six months ended in Dec. 2020 was 0.00.


Athanase Innovation AB Capex-to-Revenue Historical Data

The historical data trend for Athanase Innovation AB's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Athanase Innovation AB Capex-to-Revenue Chart

Athanase Innovation AB Annual Data
Trend Jun17 Jun18 Jun19
Capex-to-Revenue
- - -

Athanase Innovation AB Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20
Capex-to-Revenue Get a 7-Day Free Trial - - - - -

Competitive Comparison of Athanase Innovation AB's Capex-to-Revenue

For the Asset Management subindustry, Athanase Innovation AB's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Athanase Innovation AB's Capex-to-Revenue Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Athanase Innovation AB's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Athanase Innovation AB's Capex-to-Revenue falls into.



Athanase Innovation AB Capex-to-Revenue Calculation

Athanase Innovation AB's Capex-to-Revenue for the fiscal year that ended in Jun. 2019 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 42.033
=0.00

Athanase Innovation AB's Capex-to-Revenue for the quarter that ended in Dec. 2020 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0.352
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Athanase Innovation AB  (OSTO:ATIN) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Athanase Innovation AB Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Athanase Innovation AB's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Athanase Innovation AB (OSTO:ATIN) Business Description

Traded in Other Exchanges
N/A
Address
Nybrogatan 3, Stockholm, SWE, 114 34
Athanase Innovation AB is an alternative investment firm with exposure to both private and public equity. It invests in innovative companies that benefit from trends such as robotics, digitalization, and automation. The principal revenue stream is initially management fees charged on the external fund capital and investment income of the underlying assets.

Athanase Innovation AB (OSTO:ATIN) Headlines

No Headlines